Skip to main content
. 2020 Jun 1;10(6):65. doi: 10.1038/s41408-020-0331-4

Fig. 1. Presence of stromal cells protects AML and MM cell lines from T cell redirected cytotoxicity.

Fig. 1

Human T cells (40,000 cells/well) were cultured with CFSE labeled AML KG-1 (a, b) or MM H929 cell lines (c, d) 2:1 ratio in the presence or absence of stromal cells (HS-5, HS-27a, primary MSC, or CD105+ endothelial cells; 20,000 cells per well). Varying concentrations of CD123xCD3 (a, b) or BCMAxCD3 (c, d) were added to cultures for 48 h. The percentage of dead CFSE+ cells was quantitated by flow cytometry. Dose titration graphs on the left (a, c) are shown with means ± standard deviation (SD). Scatter plots on the right (b, d) show data for the highest concentration of the bispecific antibody (median with range). Data are representative of three or more experiments. ∗∗p < 0.005, ∗∗∗p < 0.0005; ∗∗∗∗p < 0.0001; n.s. not statistically significant.